Encouraging results for long-term efficacy of meningitis C vaccine

July 22, 2004

Four-year results assessing the efficacy of the UK meningitis C vaccine programme are reported in a research letter in this week's issue of THE LANCET. The vaccine is now showing long-term efficacy, except for infants initially vaccinated younger than 5 months of age.

The meningococcal serogroup C conjugate (MCC) vaccine programme was introduced in November 1999 and has successfully controlled the incidence of meningitis C--a result of high short-term vaccine effectiveness and substantial herd (population) immunity. However, the long-term effectiveness of the vaccine remains unknown.

Caroline Trotter (UK Health Protection Agency) and colleagues assessed surveillance data from the 4 years since the introduction of the vaccination programme. Vaccine effectiveness remained high in children vaccinated in the catch-up campaign (aged 5 months to 18 years) at around 90%. However, overall vaccine effectiveness was only 66% for children vaccinated in early infancy. the vaccine offered high levels of protection (>93% effectiveness) for one year, regardless of the age of the child at vaccination; however this protection rapidly diminished for children who were vaccinated in early infancy (younger than 5 months of age). With regard to this reduced protection, the authors comment: 'The number of cases of serogroup C disease in these cohorts remains low, but alternative routine immunisation schedules should be considered to ensure high levels of protection are sustained.'

Paul A Offit (University of Pennsylvania School of Medicine, Philadelphia, USA) gives an overall perspective on the UK MCC vaccination programme in an accompanying commentary (p 309): "The UK Department of Health showed how to efficiently implement an effective mass-immunisation programme with a conjugate meningococcal vaccine. The Department characterised the burden of serogroup C meningococcal infections, identified a vaccine to solve the problem, actively engaged several drug companies in the programme, and negotiated an affordable price, launched a media campaign to educate citizens about the disease and the vaccine, and immunised a remarkably high percentage of children within a year. For their efforts, the Department of Health deserves the gratitude of children and their parents throughout the world".
-end-
Contact: Health Protection Agency Press Office; T) 44-208-327-6647; hqpressofice@hpa.org.uk

Dr Paul A Offit, Childrens Hospital of Philadelphia, University of Pennsylvania, USA;
T) 215-590-2020; offit@email.chop.edu

Lancet

Related Vaccination Articles from Brightsurf:

US adults' likelihood of accepting COVID-19 vaccination
In this survey study of U.S. adults, vaccine-related attributes and political characteristics were associated with self-reported preferences for choosing a hypothetical COVID-19 vaccine and self- reported willingness to receive vaccination.

Vaccination insights
While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their counterparts.

Wording of vaccination messages influences behavior
An experiment by Washington State University researchers revealed that relatively small differences in messages influenced people's attitudes about the human papillomavirus or HPV vaccine, which has been shown to help prevent cancer.

Addressing HPV vaccination concerns
Research from the Harvard Pilgrim Health Care Institute finds a promising avenue for addressing vaccine hesitancy around HPV vaccine.

Virtual reality could help flu vaccination rates
Using a virtual reality simulation to show how flu spreads and its impact on others could be a way to encourage more people to get a flu vaccination, according to a study by researchers at the University of Georgia and the Oak Ridge Associated Universities in Oak Ridge, Tennessee.

Religion associated with HPV vaccination rate for college women
A survey of female college students finds 25% had not been vaccinated for HPV and religion may be a contributing factor.

Measles vaccination: 'All for one and one for all'
A commentary by researchers addresses the specter of clinical, ethical, public health and legal concerns that have been raised because of the recent measles outbreaks in New York.

New single vaccination approach to killer diseases
Scientists from the University of Adelaide's Research Centre for Infectious Diseases have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, the world's most deadly respiratory diseases.

Vaccination may help protect bats from deadly disease
A new study shows that vaccination may reduce the impact of white-nose syndrome in bats, marking a milestone in the international fight against one of the most destructive wildlife diseases in modern times.

Parents reassured febrile seizures following vaccination not dangerous
New University of Sydney research finds that febrile seizures after vaccination are rare, not serious and are no different to febrile seizures due to other causes such as from a virus.

Read More: Vaccination News and Vaccination Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.